| 标题 |
 Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊：The Lancet Oncology 作者：Gunter von Minckwitz; F. Puglisi; J. Cortés; E. Vrdoljak; N. Marschner; et al 出版日期：2014-10-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)
GingerF
渡人舟
神勇映雁
核桃
印第安老斑鸠
cdercder
v0id
Nole
LUOCC
科研狗
奔跑
研友_8RyB3Z
无极微光
My_magnum_opus
共产主义战士
斯文的白玉
Viper
skearthy
李蕙芯
Momomo
皖公网安备34019202002308
